All Outputs (4)

How Long Does It Take to Read a Mammogram? Investigating the Reading Time of Digital Breast Tomosynthesis and Digital Mammography (2024)
Journal Article
Partridge, G. J., Darker, I., James, J. J., Satchithananda, K., Sharma, N., Valencia, A., …Chen, Y. (2024). How Long Does It Take to Read a Mammogram? Investigating the Reading Time of Digital Breast Tomosynthesis and Digital Mammography. European Journal of Radiology, 177, Article 111535. https://doi.org/10.1016/j.ejrad.2024.111535

Purpose To analyse digital breast tomosynthesis (DBT) reading times in the screening setting, compared to 2D full-field digital mammography (FFDM), and investigate the impact of reader experience and professional group on interpretation times. Me... Read More about How Long Does It Take to Read a Mammogram? Investigating the Reading Time of Digital Breast Tomosynthesis and Digital Mammography.

A survey by the European Society of Breast Imaging on radiologists’ preferences regarding quality assurance measures of image interpretation in screening and diagnostic mammography (2023)
Journal Article
Michalopoulou, E., Clauser, P., Gilbert, F. J., Pijnappel, R. M., Mann, R. M., Baltzer, P. A., …Fallenberg, E. M. (2023). A survey by the European Society of Breast Imaging on radiologists’ preferences regarding quality assurance measures of image interpretation in screening and diagnostic mammography. European Radiology, 33, 8103-8111. https://doi.org/10.1007/s00330-023-09973-7

Objectives: Quality assurance (QA) of image interpretation plays a key role in screening and diagnostic mammography, maintaining minimum standards and supporting continuous improvement in interpreting images. However, the QA structure across Europe s... Read More about A survey by the European Society of Breast Imaging on radiologists’ preferences regarding quality assurance measures of image interpretation in screening and diagnostic mammography.

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis (2023)
Journal Article
Mózes, F. E., Lee, J. A., Vali, Y., Alzoubi, O., Staufer, K., Trauner, M., …Hytiroglou, P. (2023). Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis. The Lancet Gastroenterology & Hepatology, 8(8), 704-713. https://doi.org/10.1016/S2468-1253%2823%2900141-3

Background Histologically assessed liver fibrosis stage has prognostic significance in patients with non-alcoholic fatty liver disease (NAFLD) and is accepted as a surrogate endpoint in clinical trials for non-cirrhotic NAFLD. Our aim was to compare... Read More about Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.

Defining the road map to a UK national lung cancer screening programme (2023)
Journal Article
O'Dowd, E. L., Lee, R. W., Akram, A. R., Bartlett, E. C., Bradley, S. H., Brain, K., …Crosbie, P. (2023). Defining the road map to a UK national lung cancer screening programme. Lancet Oncology, 24(5), e207-e218. https://doi.org/10.1016/S1470-2045%2823%2900104-3

Lung cancer screening with low-dose CT was recommended by the UK National Screening Committee (UKNSC) in September, 2022, on the basis of data from trials showing a reduction in lung cancer mortality. These trials provide sufficient evidence to show... Read More about Defining the road map to a UK national lung cancer screening programme.